Hypertrophic cardiomyopathy mutations in <i>MYBPC3</i> dysregulate myosin
Christopher N. Toepfer(John Radcliffe Hospital), Christine E. Seidman(Harvard University), Hugh Watkins(John Radcliffe Hospital), Amanda C. Garfinkel(United States Nuclear Regulatory Commission), James W. McNamara(Royal Children's Hospital), Ida G. Lunde(Oslo University Hospital), Sakthivel Sadayappan(University of Arizona), Hiroko Wakimoto(Brigham and Women's Hospital), Angela C. Tai(Harvard University), Jianming Jiang(Hebei Medical University), Dan Liao(National University of Singapore), Barbara McDonough(Brigham and Women's Hospital), Charles Redwood(University of Oxford), Thomas L. Lynch(Loyola University Chicago), Joshua Gorham(Harvard University), Mingyue Lun(Brigham and Women's Hospital), Jonathan G. Seidman(Harvard University)
Cited by 215
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Cells of the adult human heart
|Nature|2020|1.8k
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2003|1.6k